Novartis is a Swiss company headquartered in Basel, focused on oncology, cardiovascular, immunology and neuroscience, with major drugs including the heart-failure treatment Entresto, the autoimmune drug Cosentyx and the CAR-T cell therapy Kymriah.
Novartis sharpened its focus on innovative medicines by spinning off its generics division Sandoz in 2023, and it faces patent expirations across its portfolio.
